Pillar Biosciences oncoReveal panels

Explore library prep kits that enable a simplified, rapid NGS workflow for targeted oncology research applications

A targeted NGS portfolio to equip your research lab

Illumina has partnered with Pillar Biosciences to offer library prep panels as part of a simplified, rapid next‑generation sequencing (NGS) workflow for oncology research. Panels include genes associated with solid tumors and hematological malignancies, as well as those designed for liquid as well as those designed for research using liquid biopsy research, that can be run on Illumina benchtop sequencing systems and analyzed with DRAGEN software.

The workflow provides accurate variant detection across a range of DNA and RNA variant types, even with limited nucleic acid input or poor sample quality. These flexible solutions improve lab efficiency and reduce "no calls" and repeat testing to simplify data interpretation.

Related content

Compare products

(0 of 4)

Add another product to compare

Add another product to compare

Add another product to compare

Add another product to compare

FAQ

All oncoReveal panels can be run on the MiSeq i100 Series for the fastest turnaround times. The panels are also compatible with MiSeq and MiSeqDx (in RUO mode) instruments and make a great compliment to TruSight Oncology 500 when run on the NextSeq 550, NextSeq 550 Dx (in RUO mode) or NextSeq 1000/2000. 

OncoReveal panels are designed using stem-loop inhibition mediated amplification (SLIMamp) chemistry enabling highly multiplexed PCR in a single tube. Tagged primers form stem-loop structures, selectively blocking unwanted amplification, reducing hands-on time, and minimizing errors. The technology’s streamlined workflow improves laboratory efficacy while maintaining high sensitivity for variant detection even at low allele frequencies.

Going from sample to result can be as fast as under 24 hours for oncoReveal panels sequenced on the MiSeq i100 Series using DRAGEN for analysis.

/ Results